All news articles for December 2010

Measure your claims carefully in 2011, unless facing an FTC complaint is one of your New Year's Resolutions

10 New Year’s Resolutions for 2011

By Ivan Wasserman

2010 saw a flurry of enforcement activity by the Federal Trade Commission (FTC) based on claims made for dietary supplement and functional food products. There is no indication that 2011 will be any different.

Quality will improve under the Food safety Bill, says industry

Industry welcomes Food Safety Bill

Industry groups have welcomed the passage of the Food Safety Bill, highlighting lobbying efforts and Congressional support that kept potential burdens out of the amended legislation.

RockHard Weekend? Unlikely, after sildenafil detection and voluntary recall

Dietary supplements firm Hain gets FDA 483 warning

By Mike Stones

Long Island-based dietary supplement firm, Hain North America has received a warning letter outlining infringements of Good Management Practice (GMP) from the Food and Drug Administration (FDA).

Industry is finding the EU health claims system hard to swallow

Are health claims making your business sick?

By Shane Starling

2010 has been another tough year for the European functional food and supplements industries as health claim rejections have continued to flood in, leaving some in a state of high anxiety, fear and dread. Others are just mildly annoyed at a situation...

The gut feeling is good between Probi and Institut Rosell as they extend probiotic link

Canadian Institut Rosell agrees probiotic deal with Probi

By Mike Stones

French Canadian company Institut Rosell has agreed a seven-year partnership with Swedish probiotic research and the development firm Probi covering dietary supplements based on its bacterial Lp299v strain.

It's cocoa, not chocolate.

Mars: Cocoa flavanols show prebiotic potential

By Stephen Daniells

Flavanol compounds derived from cocoa may boost the populations of beneficial bacteria in the intestine, says a new study from Mars and the University of Reading.

Martek becomes DSM's biggest acquisition since its 2002 purchase of Roche Vitamins

DSM buys Martek’s “algae platform” for $1bn+

By Shane Starling

Royal DSM will drive Martek’s predominantly US-based, omega-3 DHA infant nutrition business to new shores, and fast-track its food and beverage ambitions, after having its billion-dollar bid accepted by the Maryland company’s Board.

Follow us

Products

View more

Webinars